As a consequence of the Covid-19 pandemic, the management of Newton Biocapital decided to replace the "in person" informal shareholder meeting by three sessions of video conferences covering:

- financials fiscal year 2019

- highlights portfolio companies

- financials end Q1 2020 (unaudited)

- forecast